Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04740957
Other study ID # IRAS 246354
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date January 1, 2024

Study information

Verified date September 2023
Source Imperial College London
Contact James Kinross, PhD FRCS
Phone 020 3312 2124
Email j.kinross@imperial.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study aims to investigate anastomotic healing and its underlying mechanisms at a mucosal level. It is a first-in-human study which will demonstrate the safety of post-operative endoscopic assessment of a colorectal anastomosis and provide preliminary data in order to power future interventional studies. 100 patients undergoing elective left colonic or rectal resection with a primary anastomosis will be recruited pre-operatively throughout the study period. This study will not affect or delay the intended treatment for study participants. Patients will undergo serial endoscopic examination of the anastomosis post-operatively. Blood, urine, stool, and mucosal biopsies will be serially collected. A subgroup of 20 patients with a defunctioning ileostomy will be recruited to an interventional arm. This interventional arm will demonstrate the safety of re-introducing ileostomy effluent into the downstream (distal) limb of an ileostomy. The preliminary data will enable exploration of the association between microbiome and post-operative function and enable adequate powering of future interventional studies.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date January 1, 2024
Est. primary completion date January 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients undergoing elective left sided colonic or rectal resections with primary anastomosis with or without diverting ileostomy. Exclusion Criteria: - Inability to communicate in English - People who lack capacity to consent - Emergency colorectal resection whilst awaiting elective surgery - Age <18 - Permanent stoma formation - People on long term immunosuppressive medication - People on long term renal replacement therapy.

Study Design


Related Conditions & MeSH terms

  • Healing of Colorectal Anastomoses

Intervention

Other:
Distal limb reintroduction of ileostomy effluent
Patients will undergo water soluble contrast enema to confirm anastomotic healing 8 weeks post operatively as per standard practice at Imperial. Patients will be educated in how to reintroduce ileostomy output to the distal (downstream) loop of their ileostomy. They will be asked to reintroduce 50ml of ileostomy output using a conventional long-tipped bladder syringe daily until surgery to close the stoma.

Locations

Country Name City State
United Kingdom Imperial College Healthcare NHS Trust London

Sponsors (1)

Lead Sponsor Collaborator
Imperial College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes in microbial diversity Changes in microbial abundance and diversity at the anastomosis. The nature of any change is as yet not investigated and unpredictable - this is an observational outcome measure. 1 year
Primary Anastomotic healing Healing of the colorectal anastomosis when assessed endoscopically - with no visible defects in the anastomosis. 1 year
Secondary Failure of anastomotic healing Anastomotic leak detected either by radiological imaging (CT scanning) or a direct return to theatre 1 year